A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...

Lenacapavir, a long-acting injectable form of HIV prevention, is set to revolutionise HIV prevention strategies in South ...

Seattle and San Francisco scale back harm reduction policies distributing drug supplies, signaling a shift in how West Coast ...

President Trump’s anti-LGBTQ agenda dominated national news in 2025, particularly his cruel attacks on trans Americans. Here are our picks for the top 10 LGBTQ news stories the Blade covered in 2025.

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

The Trump administration's deep cuts in U.S. foreign health aid had a devastating impact. Yet there were achievements of note ...

The hope is by taking a pill only once a week, you're less likely to forget a dose, something that's critical when treating conditions like HIV.

Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a glimpse at the future of human health. A colorized transmission electron ...

WASHINGTON, Dec 12 (Reuters) - The U.S. and Eswatini signed a five-year health cooperation agreement on Friday, the State Department said, as the Trump administration continues its global health plan ...